February 9, 2019, the deadline for the Falsified Medicines Directive (FMD) is fast approaching.

Companies that do not comply with the Directive, until February, will not be able to sell their products in Europe.

To date, there is no indication of an extension of the obligation to implement traceability and serialization.

The regulations established by the FMD state that each MAH must send the serialization codes to the European Medicines Verification Organization.

Serialization seems simple. Complexity and specificity, begin by integrating business partners.

However, for smart and secure integration, with the help of an experienced serialization solution provider, you can reduce business risk, increase visibility and supply chain reliability, and add business value.

Serialization is a big challenge, but having the right solution and the right partner, like TrackTraceRx, makes all the difference.